ArticleFrontiers in molecular biosciences2023

Serum metabolomics identified specific lipid compounds which may serve as markers of disease progression in patients with Alström and Bardet-Biedl syndromes.

Krzysztof Jeziorny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.